Detection of ErbB2: Nanotechnological solutions for clinical diagnostics

RSC Advances

Volumn 4, Issue 7, 2014, Pages 3422-3442

  Mahfoud, Omar K ^a   Rakovich, Tatsiana Y ^a   Prina Mello, Adriele ^a   Movia, Dania ^a   Alves, Frauke ^b   Volkov, Yuri ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS AND EVALUATION; BIOLOGICAL SAMPLES; CLINICAL DIAGNOSTICS; DETECTION AND QUANTIFICATIONS; HUMAN EPIDERMAL GROWTH FACTOR; METASTATIC CANCERS; MOLECULAR LEVELS; OVER-EXPRESSION;

DIAGNOSIS; DRUG THERAPY;

DISEASES;

EID: 84890591034     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c3ra45401k     Document Type: Review

References (118)

1. A. Negro B. Brar Y. Gu K. Peterson W. Vale K.-F. Lee ErbB2 is required for G protein-coupled receptor signaling in the heart Proc. Natl. Acad. Sci. U. S. A. 2006 103 43 15889 15893
2. D. Yu M.-C. Hung Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene 2000 19 6115 6121
3. J. Baselga S. Swain Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 Nat. Rev. Cancer 2009 9 7 463 475
4. C. Bargmann M. Hung R. Weinberg The neu oncogene encodes an epidermal growth factor receptor-related protein Nature 1986 319 6050 226 230
5. T. Yamamoto S. Ikawa T. Akiyama K. Semba N. Nomura N. Miyajima et al. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor Nature 1986 319 6050 230 234
6. E. Lanitis D. Dangaj I. Hagemann D.-G. Song A. Best R. Sandaltzopoulos et al. Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels PLoS One 2012 7 11 e49829
7. A. Dulak S. Schumacher J. van Lieshout Y. Imamura C. Fox B. Shim et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis Cancer Res. 2012 72 17 4383 4393
8. K. Ugocsai L. Mándoky L. Tiszlavicz J. Molnár Investigation of HER2 overexpression in non-small cell lung cancer Anticancer Res. 2005 25 4 3061 3066
9. S.-C. Wang H.-C. Lien W. Xia I. F. Chen H.-W. Lo Z. Wang et al. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 Cancer Cell 2004 6 3 251 261
10. C. G. Murphy P. G. Morris Recent advances in novel targeted therapies for HER2-positive breast cancer Anticancer Drugs 2012 23 8 765 776
11. Cancer Genome Atlas N Comprehensive molecular portraits of human breast tumours Nature 2012 490 7418 61 70
12. K. Maryam M. Negar J. Azadeh S. Ahmad H. Niloufar Breast Cancer Molecular Subtypes and Associations with Clinicopathological Characteristics in Iranian Women, 2002-2011 Asian Pacific Journal of Cancer Prevention 2012 13 1881 1886
13. L. Wiechmann M. Sampson M. Stempel L. Jacks S. Patil T. King et al. Presenting features of breast cancer differ by molecular subtype Ann. Surg. Oncol. 2009 16 10 2705 2710
14. D. N. Amin N. Sergina D. Ahuja M. McMahon J. A. Blair D. Wang et al. Resiliency and vulnerability in the HER2-HER3 tumorigenic driver Sci. Transl. Med. 2010 2 16 16ra7
15. P. C. C. Liu X. Liu Y. Li M. Covington R. Wynn R. Huber et al. Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells Cancer Biol. Ther. 2006 5 6 657 664
16. W. Carney R. Neumann A. Lipton K. Leitzel S. Ali C. Price Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer Clin. Chem. 2003 49 10 1579 1598
17. W. P. Carney D. Bernhardt B. Jasani Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients? Biomarkers Cancer 2013 5 31 39
18. J. Ross J. Fletcher G. Linette J. Stec E. Clark M. Ayers et al. The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy Oncologist 2003 8 4 307 325
19. F. Penault-Llorca J. Adelaïde G. Houvenaeghel J. Hassoun D. Birnbaum J. Jacquemier Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation J. Pathol. 1994 173 1 65 75
20. F. R. Hirsch M. Varella-Garcia F. Cappuzzo Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer Oncogene 2009 28 Suppl. 1 S32 S37
21. Y. Liu Q. Liu T. Wang L. Bian S. Zhang H. Hu et al. Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker BMC Cancer 2013 13 202
22. T. Fehm V. Müller B. Aktas W. Janni A. Schneeweiss E. Stickeler et al. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial Breast Cancer Res. Treat. 2010 124 2 403 412
23. B. R. Waterhouse M. Gijsen P. R. Barber I. D. C. Tullis B. Vojnovic A. Kong Assessment of EGFR/HER2 dimerization by FRET-FLIM utilizing Alexa-conjugated secondary antibodies in relation to targeted therapies in cancers Oncotarget 2011 2 9 728 736
24. N. Gaborit C. Larbouret J. Vallaghe F. Peyrusson C. Bascoul-Mollevi E. Crapez et al. Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: a new method to evaluate the efficiency of targeted therapy using monoclonal antibodies J. Biol. Chem. 2011 286 13 11337 11345
25. J. Napp J. E. Mathejczyk F. Alves Optical imaging in vivo with a focus on paediatric disease: technical progress, current preclinical and clinical applications and future perspectives Pediatr. Radiol. 2011 41 2 161 175
26. F. Patolsky G. Zheng C. Lieber Nanowire sensors for medicine and the life sciences Nanomedicine 2006 1 1 51 65
27. G.-J. Zhang Y. Ning Silicon nanowire biosensor and its applications in disease diagnostics: a review Anal. Chim. Acta 2012 749 1 15
28. A. Prina-Mello A. Whelan A. Atzberger J. McCarthy F. Byrne G.-L. Davies et al. Comparative flow cytometric analysis of immunofunctionalized nanowire and nanoparticle signatures Small 2010 6 2 247 255
29. S. Bhaskar F. Tian T. Stoeger W. Kreyling J. de la Fuente V. Grazú et al. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging Part. Fibre Toxicol. 2010 7 1 3
30. C. S. S. R. Kumar, Nanomaterials for Medical Diagnosis and Therapy, ed., C. S. S. R. Kumar, WILEY-VCH, Weinheim, 2007
31. C. S. S. R. Kumar, Nanomaterials for Cancer Diagnosis, ed., C. S. S. R. Kumar, WILEY-VCH, Weinheim, 2006
32. C. Schütz L. Juillerat-Jeanneret H. Mueller I. Lynch M. Riediker Therapeutic nanoparticles in clinics and under clinical evaluation Nanomedicine 2013 8 3 449 467
33. M. L. Etheridge S. A. Campbell A. G. Erdman C. L. Haynes S. M. Wolf J. McCullough The big picture on nanomedicine: the state of investigational and approved nanomedicine products Nanomedicine 2013 9 1 1 14
34. W. Carney R. Neumann A. Lipton K. Leitzel Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer Breast Cancer 2004 5 2 105 116
35. Z. Storchova D. Pellman From polyploidy to aneuploidy, genome instability and cancer Nat. Rev. Mol. Cell Biol. 2004 5 1 45 54
36. S. Zhang I. Mercado-Uribe Z. Xing B. Sun J. Kuang J. Liu Generation of cancer stem-like cells through the formation of polyploid giant cancer cells Oncogene 2013.
37. A. Cayre F. Mishellany N. Lagarde F. Penault-Llorca Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification Breast Cancer Res. 2007 9 5 R64
38. C. O'Connor Fluorescence in situ hybridization (FISH) Nature 2008 1 1 171
39. J. Alba J. Gutierrez V. M. Coupe B. Fernández Á. Vázquez-Boquete J. Alba et al. HER2 status determination using RNA-ISH-a rapid and simple technique showing high correlation with FISH and IHC in 141 cases of breast cancer Histol. Histopathol. 2012 27 8 1021 1027
40. G. Tsongalis Branched DNA technology in molecular diagnostics Am. J. Clin. Pathol. 2006 126 3 448 453
41. T. Horn C. Chang M. Urdea Chemical synthesis and characterization of branched oligodeoxyribonucleotides (bDNA) for use as signal amplifiers in nucleic acid quantification assays Nucleic Acids Res. 1997 25 23 4842 4849
42. S. Cavallaro S. Paratore F. de Snoo E. Salomone L. Villari C. Buscarino et al. Genomic analysis: Toward a new approach in breast cancer management Crit. Rev. Oncol. Hematol. 2012 81 3 207 223
43. E. A. Slodkowska J. S. Ross MammaPrint™ 70-gene signature: another milestone in personalized medical care for breast cancer patients Expert Rev. Mol. Diagn. 2009 9 5 417 422
44. M. Cronin C. Sangli M.-L. Liu M. Pho D. Dutta A. Nguyen et al. Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor-Positive Breast Cancer Clin. Chem. 2007 53 6 1084 1091
45. H. L. McArthur, E. Brogi, S. Patil, M. Wigler, L. Norton and J. Hicks, et al. High resolution microarray copy number analysis (array CGH) suggests that determination of HER2 amplification by FISH (FISH+) is inaccurate in human breast cancer specimens that are HER2 2+ by immunohistochemistry (IHC2+), in Joint ECCO 15-34th ESMO Multidisciplinary Congress, ed, J. Smyth, 20-24 September BERLIN: European Journal of Cancer Supplements, 2009, p. 88
46. M. Allison The HER2 testing conundrum Nat. Biotechnol. 2010 28 2 117 119
47. J. Arribas J. Baselga K. Pedersen J. L. Parra-Palau p95HER2 and breast cancer Cancer Res. 2011 71 5 1515 1519
48. L. True X. Gao Quantum dots for molecular pathology: their time has arrived J. Mol. Diagn. 2007 9 1 7 11
49. R. Molina J. Jo X. Filella J. Bruix A. Castells M. Hague et al. Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases Tumour Biol. 1997 18 3 188 196
50. L. Lam N. McAndrew M. Yee T. Fu J. C. Tchou H. Zhang Challenges in the clinical utility of the serum test for HER2 ECD Biochim. Biophys. Acta 2012 1826 1 199 208
51. X. Chi D. Huang Z. Zhao Z. Zhou Z. Yin J. Gao Nanoprobes for in vitro diagnostics of cancer and infectious diseases Biomaterials 2012 33 1 189 206
52. S. Ray P. Reddy S. Choudhary D. Raghu S. Srivastava Emerging nanoproteomics approaches for disease biomarker detection: a current perspective J. Proteomics 2011 74 12 2660 2681
53. K. Costas K. Olga Nanoscale carriers for targeted delivery of drugs and therapeutic biomolecules Can. J. Chem. Eng. 2013 91 2660 2681
54. A. Martin B. Li E. Gillies Surface functionalization of nanomaterials with dendritic groups: toward enhanced binding to biological targets J. Am. Chem. Soc. 2009 131 2 734 741
55. D. K. Bhowmick S. Linden A. Devaux L. De Cola H. Zacharias Functionalization of Amorphous SiO2 and 6H-SiC(0001) Surfaces with Benzo[ghi]perylene-1,2-Dicarboxylic Anhydride via an APTES Linker Small 2012 8 4 592 601
56. M. Walling J. Novak J. Shepard Quantum dots for live cell and in vivo imaging Int. J. Mol. Sci. 2009 10 2 441 491
57. A. Sukhanova K. Even-Desrumeaux A. Kisserli T. Tabary B. Reveil J.-M. Millot et al. Oriented conjugates of single-domain antibodies and quantum dots: toward a new generation of ultrasmall diagnostic nanoprobes Nanomedicine: nanotechnology, biology and medicine 2012 8 4 516 525
58. A. Sukhanova, K. Even-Desrumeaux, J.-M. Millot, P. Chames, D. Baty and M. Artemyev, et al., Oriented conjugates of monoclonal and single-domain antibodies with quantum dots for flow cytometry and immunohistochemistry diagnostic applications, Proc SPIE 8232, Colloidal Nanocrystals for Biomedical Applications VII; 2012/02/09
59. H. Hathaway K. Butler N. Adolphi D. Lovato R. Belfon D. Fegan et al. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors Breast Cancer Res. 2011 13 5 R108
60. Y. Xiao P. Barker Semiconductor nanocrystal probes for human metaphase chromosomes Nucleic Acids Res. 2004 32 3 e28
61. D. Ioannou H. Tempest B. Skinner A. Thornhill M. Ellis D. Griffin Quantum dots as new-generation fluorochromes for FISH: an appraisal Chromosome Res. 2009 17 4 519 530
62. D. Larson W. Zipfel R. Williams S. Clark M. Bruchez F. Wise et al. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo Science 2003 300 5624 1434 1436
63. A. Smith S. Dave S. Nie L. True X. Gao Multicolor quantum dots for molecular diagnostics of cancer Expert Rev. Mol. Diagn. 2006 6 2 231 244
64. C. Chen J. Peng H. Xia Q. Wu L. Zeng H. Xu et al. Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity Nanotechnology 2010 21 9 95101
65. W. Mahmoud A. Sukhanova V. Oleinikov Y. Rakovich J. Donegan M. Pluot et al. Emerging applications of fluorescent nanocrystals quantum dots for micrometastases detection Proteomics 2010 10 4 700 716
66. X. Wu H. Liu J. Liu K. Haley J. Treadway J. Larson et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots Nat. Biotechnol. 2003 21 1 41 46
67. M. Howarth K. Takao Y. Hayashi A. Ting Targeting quantum dots to surface proteins in living cells with biotin ligase Proc. Natl. Acad. Sci. U. S. A. 2005 102 21 7583 7588
68. C. Chen J. Peng H.-S. Xia G.-F. Yang Q.-S. Wu L.-D. Chen et al. Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer Biomaterials 2009 30 15 2912 2918
69. C. Chen H.-S. Xia Y.-P. Gong J. Peng C.-W. Peng M.-B. Hu et al. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis Biomaterials 2010 31 33 8818 8825
70. A. Generalova S. Sizova T. Zdobnova M. Zarifullina M. Artemyev A. Baranov et al. Submicron polymer particles containing fluorescent semiconductor nanocrystals CdSe/ZnS for bioassays Nanomedicine 2011 6 2 195 209
71. B. Barat S. Sirk K. McCabe J. Li E. Lepin R. Remenyi et al. Cys-diabody quantum dot conjugates (immunoQdots) for cancer marker detection Bioconjugate Chem. 2009 20 8 1474 1481
72. N. Barteneva and I. Vorobjev. Quantum dots in microscopy and cytometry: immunostaining applications. 2010
73. K. Maiti U. Dinish C. Fu J.-J. Lee K.-S. Soh S.-W. Yun et al. Development of biocompatible SERS nanotag with increased stability by chemisorption of reporter molecule for in vivo cancer detection Biosens. Bioelectron. 2010 26 2 398 403
74. A. Samanta K. Maiti K.-S. Soh X. Liao M. Vendrell U. Dinish et al. Ultrasensitive near-infrared Raman reporters for SERS-based in vivo cancer detection Angew. Chem., Int. Ed. 2011 50 27 6089 6092
75. K. L. Kelly C. Eduardo Z. Lin Lin C. S. George The Optical Properties of Metal Nanoparticles: The Influence of Size, Shape, and Dielectric Environment J. Phys. Chem. B 2003 107 668 677
76. K. Seekell M. Crow S. Marinakos J. Ostrander A. Chilkoti A. Wax Hyperspectral molecular imaging of multiple receptors using immunolabeled plasmonic nanoparticles J. Biomed. Opt. 2011 16 11 116003
77. M. Crow K. Seekell J. Ostrander A. Wax Monitoring of receptor dimerization using plasmonic coupling of gold nanoparticles ACS Nano 2011 5 11 8532 8540
78. F. Lyng E. Ó. Faoláin J. Conroy A. Meade P. Knief B. Duffy et al. Vibrational spectroscopy for cervical cancer pathology, from biochemical analysis to diagnostic tool Exp. Mol. Pathol. 2007 82 121 129
79. M. Porter R. Lipert L. Siperko G. Wang R. Narayanan SERS as a bioassay platform: fundamentals, design, and applications Chem. Soc. Rev. 2008 37 5 1001 1011
80. W. Lu S. Arumugam D. Senapati A. Singh T. Arbneshi S. Khan et al. Multifunctional oval shaped gold nanoparticle based selective detection of breast cancer cells using two photon scattering assay ACS Nano 2010 4 3 1739 1749
81. S. Mucelli M. Zamuner M. Tormen G. Stanta P. Ugo Nanoelectrode ensembles as recognition platform for electrochemical immunosensors Biosens. Bioelectron. 2008 23 12 1900 1903
82. W. Lu S. Arumugam D. Senapati A. Singh T. Arbneshi S. Khan et al. Multifunctional oval-shaped gold-nanoparticle-based selective detection of breast cancer cells using simple colorimetric and highly sensitive two-photon scattering assay ACS Nano 2010 4 3 1739 1749
83. A. Ghazani, C. Castro, R. Gorbatov, H. Lee and R. Weissleder. Sensitive and direct detection of circulating tumor cells by multimarker μ-nuclear magnetic resonance, Neoplasia, New York, NY, 2012, vol. 14 (5), pp. 388-395
84. A. De Grand J. Frangioni An Operational Near-Infrared Fluorescence Imaging System Prototype for Large Animal Surgery Technol. Cancer Res. Treat. 2003 2 6 1 10
85. T. L. Doane C. Burda The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy Chem. Soc. Rev. 2012 41 7 2885 2911
86. A. Prina-Mello K. Crosbie-Staunton G. Salas M. del Puerto Morales Y. Volkov Multiparametric Toxicity Evaluation of SPIONs by High Content Screening Technique: Identification of Biocompatible Multifunctional Nanoparticles for Nanomedicine IEEE Trans. Magn. 2013 49 1 377 382
87. R. M. Sánchez-Martín, L. Alexander and M. Bradley, Multifunctionalized Biocompatible Microspheres for Sensing, Annals of the New York Academy of Sciences, 2008, p. 1130, Fluorescence Methods and Applications: Spectroscopy, Imaging, and Probes, 207-17
88. J. T. Seil T. J. Webster Antimicrobial applications of nanotechnology: methods and literature Int. J. Nanomed. 2012 7 2767 2781
89. S. Jain D. G. Hirst J. M. O'Sullivan Gold nanoparticles as novel agents for cancer therapy Br. J. Radiol. 2012 85 1010 101 113
90. K. Tiwari Dhermendra J. Takashi B. Jitendra Bio-distribution and toxicity assessment of intravenously injected anti-HER2 antibody conjugated CdSE/ZnS quantum dots in Wistar Rats Int. J. Nanomed. 2011 6 463 475
91. K. Yang C. Zhao Y. A. Cao H. Tang Y. L. Bai H. Huang et al. In vivo and in situ imaging of head and neck squamous cell carcinoma using near-infrared fluorescent quantum dot probes conjugated with epidermal growth factor receptor monoclonal antibodies in mice Oncol. Rep. 2012 27 6 1925 1931
92. D. Movia, C. Poland, L. Tran, Y. Volkov and A. Prina-Mello. Multilayered nanoparticles for personalized medicine: translation into clinical markets, Handbook of Clinical Nanomedicine: From Bench to Bedside, Pan Stanford Publishing, 2013
93. E. C. Dreaden A. M. Alkilany X. Huang C. J. Murphy M. A. El-Sayed The golden age: gold nanoparticles for biomedicine Chem. Soc. Rev. 2012 41 7 2740 2779
94. O. Veiseh J. W. Gunn M. Zhang Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging Adv. Drug Delivery Rev. 2010 62 3 284 304
95. S. Hilderbrand R. Weissleder Near-infrared fluorescence: application to in vivo molecular imaging Curr. Opin. Chem. Biol. 2010 14 1 71 79
96. J. Escobedo O. Rusin S. Lim R. Strongin NIR dyes for bioimaging applications Curr. Opin. Chem. Biol. 2010 14 1 64 70
97. H. Hong T. Gao W. Cai Molecular Imaging with Single-Walled Carbon Nanotubes Nano Today 2009 4 3 252 261
98. K. Yong I. Roy H. Ding E. Bergey P. Prasad Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications Small 2009 5 17 1997
99. J. Gao K. Chen Z. Miao G. Ren X. Chen S. Gambhir et al. Affibody-based nanoprobes for HER2-expressing cell and tumor imaging Biomaterials 2011 32 8 2141 2148
100. T. Behnke J. Mathejczyk R. Brehm C. Würth F. Gomes C. Dullin et al. Target-specific nanoparticles containing a broad band emissive NIR dye for the sensitive detection and characterization of tumor development Biomaterials 2013 34 1 160 170
101. M. D. Austin C. W. C. Warren N. B. Sangeeta Probing the Cytotoxicity of Semiconductor Quantum Dots Nano Lett. 2004 4
102. S. Suresh D. Arivuoli Nanomaterials for Nonlinear Optical (NLO) Applications: a Review Rev. Adv. Mater. Sci. 2012 30 243 253
103. R. Bäumner L. Bonacina J. Enderlein J. Extermann T. Fricke-Begemann G. Marowsky et al. Evanescent-field-induced second harmonic generation by noncentrosymmetric nanoparticles Opt. Express 2010 18 22 23218 23225
104. W. Kalender X-ray computed tomography Phys. Med. Biol. 2006 51 13 43
105. J. Hainfeld M. O'Connor F. Dilmanian D. Slatkin D. Adams H. Smilowitz Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions Br. J. Radiol. 2011 84 1002 526 533
106. Y. Liu K. Ai L. Lu Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications Acc. Chem. Res. 2012 45 10 1817 1827
107. Q.-Y. Cai S. Kim K. Choi S. Kim S. Byun K. Kim et al. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice Invest. Radiol. 2007 42 12 797 806
108. E. A. Morris Breast cancer imaging with MRI Radiologic Clinics of North America 2002 40 3 443 466
109. M. Lemort A. Canizares-Perez A. Van der Stappen S. Kampouridis Progress in magnetic resonance imaging of brain tumours Curr. Opin. Oncol. 2007 19 6 616 622
110. L. Sampath S. Kwon S. Ke W. Wang R. Schiff M. Mawad et al. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer J. Nucl. Med. 2007 48 9 1501 1510
111. S. Laurent M. Mahmoudi Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer Int. J. Mol. Epidemiol. Genet. 2011 2 4 367 390
112. H.-M. Yang C. Park M.-A. Woo M. Kim Y. Jo H. Park et al. HER2/neu Antibody Conjugated Poly(amino acid)-Coated Iron Oxide Nanoparticles for Breast Cancer MR Imaging Biomacromolecules 2010 11 2886 2872
113. Y. Mi K. Li Y. Liu K.-Y. Pu B. Liu S.-S. Feng Herceptin functionalized polyhedral oligomeric silsesquioxane-conjugated oligomers-silica/iron oxide nanoparticles for tumor cell sorting and detection Biomaterials 2011 32 32 8226 8233
114. F. Kievit Z. Stephen O. Veiseh H. Arami T. Wang V. Lai et al. Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs ACS Nano 2012 6 3 2591 2601
115. E. Flynn H. Bryant A biomagnetic system for in vivo cancer imaging Phys. Med. Biol. 2005 50 6 1273 1293
116. Magnetic Sentinel Lymph Node Detection for Breast Cancer Thirty-Third Annual CTRC-AACR San Antonio Breast Cancer Symposium, ed., L. Johnson, Q. Pankhurst, A. Purushotham, A. Brazdeikis, M. Douek, San Antonio, 2010
117. N. Adolphi K. Butler D. Lovato T. Tessier J. Trujillo H. Hathaway et al. Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI Contrast Media Mol. Imaging 2012 7 3 308 319
118. A. M. Nightingale J. C. de Mello Microscale synthesis of quantum dots J. Mater. Chem. 2010 20 8454 8463